BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15829324)

  • 1. Poor correspondence between clinical and pathologic staging in stage 1 non-small cell lung cancer: results from CALGB 9761, a prospective trial.
    D'Cunha J; Herndon JE; Herzan DL; Patterson GA; Kohman LJ; Harpole DH; Kernstine KH; Kern JA; Green MR; Maddaus MA; Kratzke RA;
    Lung Cancer; 2005 May; 48(2):241-6. PubMed ID: 15829324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biopsy first: Lessons learned from Cancer and Leukemia Group B (CALGB) 140503.
    Kohman LJ; Gu L; Altorki N; Scalzetti E; Veit LJ; Wallen JM; Wang X
    J Thorac Cardiovasc Surg; 2017 Jun; 153(6):1592-1597. PubMed ID: 28274562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Accuracy of Clinical Staging of Stage I-IIIa Non-Small Cell Lung Cancer: An Analysis Based on Individual Participant Data.
    Navani N; Fisher DJ; Tierney JF; Stephens RJ; Burdett S;
    Chest; 2019 Mar; 155(3):502-509. PubMed ID: 30391190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of regular chest computed tomography in postoperative surveillance for surgically resected non-small cell lung cancer based on TNM 8th staging system.
    Suzuki J; Miyoshi T; Tane K; Onodera K; Koike Y; Sakai T; Samejima J; Aokage K; Tsuboi M
    Gen Thorac Cardiovasc Surg; 2024 May; 72(5):346-354. PubMed ID: 38143254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCL2, CCL8, CXCL12 chemokines in resectable non-small cell lung cancer (NSCLC).
    Drosslerova M; Sterclova M; Taskova A; Hytych V; Richterova E; Bruzova M; Spunda M; Komarc M; Koziar Vasakova M
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2023 Dec; 167(4):335-339. PubMed ID: 36628560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards optimal pathologic staging of resectable non-small cell lung cancer.
    Osarogiagbon RU; Darling GE
    Transl Lung Cancer Res; 2013 Oct; 2(5):364-71. PubMed ID: 25806255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Profiles, diagnostic process, and patterns of care of patients with stage III non-small cell lung cancer: A French national study.
    Auliac JB; Greillier L; Martin E; Falcoz PE; Boisselier P; Ano S; Lefrançois M; Cortot A
    Respir Med Res; 2024 Jan; 85():101087. PubMed ID: 38657298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer and Leukemia Group B 140503: Is it time to turn the page on Lung Cancer Study Group 821?
    Altorki NK; Chow OS
    J Thorac Cardiovasc Surg; 2024 Jan; 167(1):367-370. PubMed ID: 37597739
    [No Abstract]   [Full Text] [Related]  

  • 9. Is there clinical value to prognostic signatures in early-stage NSCLC?
    Bunn PA; Hirsch FR; Aisner DL
    Clin Cancer Res; 2014 Apr; 20(7):1727-9. PubMed ID: 24583801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and surgical-pathological staging in early non-small cell lung cancer.
    Koukis I; Gkiozos I; Ntanos I; Kainis E; Syrigos KN
    Oncol Rev; 2013 Apr; 7(1):e7. PubMed ID: 25992228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synchronous Multiple Primary Cancers of the Lung: The Rare Association of Non-Small Cell Carcinoma With a Carcinoid Tumor.
    Parsi M; Vivacqua RJ
    Cureus; 2020 Aug; 12(8):e9888. PubMed ID: 32968554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiologic and histopathologic features of hydrogel sealant after lung resection in participants of a prospective randomized clinical trial.
    Moussa AM; Hui Y; Araujo Filho JA; Muallem N; Li D; Jihad M; Hsu M; Moskowitz CS; Travis WD; Solomon SB; Ginsberg MS; Maybody M
    Clin Imaging; 2023 Mar; 95():92-96. PubMed ID: 36706641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung cancer from suspicion to treatment: An indicator of healthcare access in Turkey.
    Kızılırmak D; Yılmaz Kaya Z; Gökçimen G; Havlucu Y; Cengiz Özyurt B; Gündoğuş B; Esendağlı D; Serez Kaya B; Yılmam İ; Aydemir Y; Çolak M; Afşin E; Çetin N; İdikut A; Değirmenci C; Oral Tapan Ö; Gündüz Gürkan C; Kocatürk Cİ; Ömeroğlu Şimşek G; Kalafat CE; Özgün Niksarlıoğlu EY; Ergün Serdaroğlu M; Karcıoğlu O; Özyurt S; Karahacıoğlu Madran E; Yaprak Bayrak B; Alasgarova Z; Baydar Toprak O; Yılmazel Uçar E; Topal BN; Argun Barış S; Guliyev E; Güzel E; Küçük S; Ocaklı B; Baran Ketencioğlu B; Selçuk NT; Sarı Akyüz M; Sercan Özgür E; Yetkin NA; Çetinkaya PD; Deniz PP; Atlı S; Çetindoğan H; Karakaş FG; Yılmaz ES; Ergün D; Ergün R; Tulay CM; Ünsal M; Demirkaya İ; Marım F; Kaya İ; Demirdöğen E; Görek Dilektaşlı A; Ursavaş A; Çelik P
    Cancer Epidemiol; 2023 Dec; 87():102480. PubMed ID: 37897971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors affecting accuracy of clinical staging in resectable non-small cell lung cancer in a real-world study.
    Gwon HR; La Woo A; Yong SH; Park Y; Kim SY; Kim EY; Jung JY; Kang YA; Park MS; Park SY; Lee SH
    Thorac Cancer; 2024 Mar; 15(9):730-737. PubMed ID: 38380557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage at Diagnosis Following Delay to Interval Scans for Indeterminate Nodules in Lung Cancer Screening: An Observational Study Examining the Outcomes of CHEST Expert Panel Recommendations.
    Creamer AW; Horst C; Dickson JL; Tisi S; Hall H; Verghese P; Prendecki R; Bhamani A; Khaw CR; McCabe J; Limani T; Gyertson K; Hacker AM; Teague J; Farrelly L; Dawadi S; Hackshaw A; Devaraj A; Nair A; Janes SM;
    Chest; 2024 Apr; 165(4):1020-1024. PubMed ID: 37914027
    [No Abstract]   [Full Text] [Related]  

  • 16. Development and validation of prognostic nomogram for T
    Mei W; Yao W; Song Z; Jiao W; Zhu L; Huang Q; An C; Shi J; Yu G; Sun P; Zhang Y; Shen J; Xu C; Yang H; Wang Q; Zhu Z
    BMC Cancer; 2023 Jul; 23(1):715. PubMed ID: 37525124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the Outcomes between Systematic Lymph Node Dissection and Lobe-Specific Lymph Node Dissection for Stage I Non-small Cell Lung Cancer.
    Huang CC; Tang EK; Shu CW; Chou YP; Goan YG; Tseng YC
    Diagnostics (Basel); 2023 Apr; 13(8):. PubMed ID: 37189500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and oncological outcomes of video-assisted thoracic surgery versus thoracotomy for pathologic N2 disease in non-small cell lung cancer: A comprehensive systematic review and meta-analysis.
    Li X; Huang K; Deng H; Zheng Q; Xiao T; Yu J; Zhou Q
    Thorac Cancer; 2022 Nov; 13(21):2917-2928. PubMed ID: 36102196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comparative Analysis of Video-Assisted Thoracoscopic Surgery and Thoracotomy in Non-Small-Cell Lung Cancer in Terms of Their Oncological Efficacy in Resection: A Systematic Review.
    Nath TS; Mohamed N; Gill PK; Khan S
    Cureus; 2022 May; 14(5):e25443. PubMed ID: 35774656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A standard for hilar and intrapulmonary lymph node dissection and pathological examination in early non-small cell lung cancer.
    Zhu Z; Mei W; Song Z; Jiao W; Huang Q; Zhu L; An C; Shi J; Wang W; Yu G; Sun P; Zhang Y; Shen J; Song Y; Gilbert S; Ruetzler K; Villamizar NR; Xu C; Qian J; Yao W; Yang H;
    Transl Lung Cancer Res; 2021 Dec; 10(12):4587-4599. PubMed ID: 35070763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.